Xela Domains Logo

PSILOCINMEDS.COM

psilocinmeds.com is a plural psilocin education domain for sale for formulary pages, where lawful.

WELCOME TO PSILOCINMEDS.COM

PSILOCINMEDS.COM is plural catalog English: Psilocin Meds—formulary pages and education hubs that already say “psilocin meds” when they mean multi-SKU or pathway catalogs, not singular PsilocinMed clinic tone.

Best-fit buyers: education publishers; clinic networks; investor decks; defensive holders. Exact-fit launch: a Psilocin Meds catalog hub with pathway tiles, safety FAQ, and waitlist CTA.

The same COMP005 Phase 3 result—−3.6 MADRS at week 6 vs placebo (p<0.001)—is the clinical proof-point buyers already model against medical-psychedelic catalogs.[1] Part A’s 258 dosed participants across 32 U.S. sites show the multi-site operational reality behind plural “meds” framing.[2] That pivotal spine frames why exact Psilocin Meds inventory matters—not an invented category TAM.

Why Choose PSILOCINMEDS.COM

BUY NOW - $19,318

Buy Now — PSILOCINMEDS.COM. Own the Psilocin Meds hostname.

MAKE AN OFFER

Purchase PSILOCINMEDS.COM today through our trusted partners:

WHAT DOES ALINA IWANSON THINK?

Alina Iwanson

"PsilocinMeds.com is the plural, for research-education content."

Alina Iwanson, Auction Specialist
Contact Alina Iwanson via Email

Browse Rx and pharmacy domains

Contact Us

Feel free to reach out to explore the potentials of PSILOCINMEDS.COM for your business. 📬

📧 Email: info@xeladomains.com
📞 Phone: (858) 429-9352

Social Networks

Follow our journey and connect with us on Instagram and LinkedIn for updates and more information.

Instagram | LinkedIn

REFERENCES

  1. Compass Pathways — COMP005 Phase 3: COMP360 25 mg vs placebo −3.6 MADRS at week 6 (p<0.001); FDA Breakthrough Therapy for TRD
  2. Compass Pathways — COMP005 Part A: 258 participants dosed across 32 U.S. sites (synthesized psilocybin TRD pivotal)

Last updated: Oct 2026